Novartis Institutes for BioMedical Research, Inc. Insider Trading $NTLA Intellia Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Novartis Institutes for BioMedical Research, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Novartis Institutes for BioMedical Research, Inc.. Novartis Institutes for BioMedical Research, Inc. is 10% Owner in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Surface Oncology, Inc. ($SURF).
Novartis Institutes for BioMedical Research, Inc. in Intellia Therapeutics, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Novartis Institutes for BioMedical Research, Inc.: 10% Owner
Holdings: 4,129,903 shares
Current Value: $54,927,710
Latest Transaction: Dec 14 2017
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Novartis Institutes for BioMedical Research, Inc. in Intellia Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14 2017 | NTLA | Intellia Therapeut ... | Novartis Institutes for BioMed ... | 10% Owner | Sell | S | 18.30 | 1,523,000 | 27,870,900 | 4,129,903 | 5.7 M to 4.1 M (-26.94 %) |
| Mar 07 2017 | NTLA | Intellia Therapeut ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | J | 0.00 | 79,245 | 0 | 5,652,903 | 5.6 M to 5.7 M (+1.42 %) |
| May 11 2016 | NTLA | Intellia Therapeut ... | Novartis Institutes for BioMed ... | 10% Owner | Option Exercise | C | 0.00 | 761,905 | 0 | 0 | |
| May 11 2016 | NTLA | Intellia Therapeut ... | Novartis Institutes for BioMed ... | 10% Owner | Option Exercise | C | 0.00 | 2,666,666 | 0 | 0 | |
| May 11 2016 | NTLA | Intellia Therapeut ... | Novartis Institutes for BioMed ... | 10% Owner | Option Exercise | C | 0.00 | 4,761,905 | 0 | 0 | |
| May 11 2016 | NTLA | Intellia Therapeut ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | P | 18.00 | 277,777 | 4,999,986 | 5,573,658 | 5.3 M to 5.6 M (+5.25 %) |
| May 11 2016 | NTLA | Intellia Therapeut ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | C | 0.00 | 492,640 | 0 | 5,295,881 | 4.8 M to 5.3 M (+10.26 %) |
| May 11 2016 | NTLA | Intellia Therapeut ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | C | 0.00 | 1,724,240 | 0 | 4,803,241 | 3.1 M to 4.8 M (+56.00 %) |
| May 11 2016 | NTLA | Intellia Therapeut ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | C | 0.00 | 3,079,001 | 0 | 3,079,001 | 0 to 3.1 M |
Page: 1